These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19645626)

  • 1. Mutations in MYH9 exons 1, 16, 26, and 30 are infrequently found in Japanese patients with nonsyndromic deafness.
    Kunishima S; Matsunaga T; Ito Y; Saito H
    Genet Test Mol Biomarkers; 2009 Oct; 13(5):705-7. PubMed ID: 19645626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9.
    Lalwani AK; Goldstein JA; Kelley MJ; Luxford W; Castelein CM; Mhatre AN
    Am J Hum Genet; 2000 Nov; 67(5):1121-8. PubMed ID: 11023810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17.
    Verver E; Pecci A; De Rocco D; Ryhänen S; Barozzi S; Kunst H; Topsakal V; Savoia A
    Clin Genet; 2015 Jul; 88(1):85-9. PubMed ID: 24890873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions.
    Kunishima S; Matsushita T; Kojima T; Amemiya N; Choi YM; Hosaka N; Inoue M; Jung Y; Mamiya S; Matsumoto K; Miyajima Y; Zhang G; Ruan C; Saito K; Song KS; Yoon HJ; Kamiya T; Saito H
    J Hum Genet; 2001; 46(12):722-9. PubMed ID: 11776386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COL4A5-associated X-linked Alport syndrome in a female patient with early inner ear deafness due to a mutation in MYH9.
    Strasser K; Hoefele J; Bergmann C; Büscher AK; Büscher R; Hoyer PF; Weber S
    Nephrol Dial Transplant; 2012 Nov; 27(11):4236-40. PubMed ID: 23144074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.
    Heath KE; Campos-Barros A; Toren A; Rozenfeld-Granot G; Carlsson LE; Savige J; Denison JC; Gregory MC; White JG; Barker DF; Greinacher A; Epstein CJ; Glucksman MJ; Martignetti JA
    Am J Hum Genet; 2001 Nov; 69(5):1033-45. PubMed ID: 11590545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the first duplication in MYH9-related disease: a hot spot for unequal crossing-over within exon 24 of the MYH9 gene.
    De Rocco D; Pujol-Moix N; Pecci A; Faletra F; Bozzi V; Balduini CL; Savoia A
    Eur J Med Genet; 2009; 52(4):191-4. PubMed ID: 19450438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
    Kunishima S
    Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of hearing loss in a mouse model for DFNA17 and MYH9-related disease: the use of public gene-targeted ES cell resources.
    Parker LL; Gao J; Zuo J
    Brain Res; 2006 May; 1091(1):235-42. PubMed ID: 16630581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the understanding of MYH9 disorders.
    Kunishima S; Saito H
    Curr Opin Hematol; 2010 Sep; 17(5):405-10. PubMed ID: 20601875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestation and molecular genetic characterization of MYH9 disorders.
    Provaznikova D; Geierova V; Kumstyrova T; Kotlin R; Mikulenkova D; Zurkova K; Matoska V; Hrachovinova I; Rittich S
    Platelets; 2009 Aug; 20(5):289-96. PubMed ID: 19557653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The MYH9 syndrome: report of a new case with a new mutation of the MYH9 gene].
    Schleinitz N; Favier R; Mazodier K; Difeo A; Ebbo M; Veit V; Berda-Haddad Y; Bernit E; Heudier P; Kaplanski G; Camoin L; Bardet V; Harle JR
    Rev Med Interne; 2006 Oct; 27(10):783-6. PubMed ID: 16978745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease.
    Pecci A; Panza E; Pujol-Moix N; Klersy C; Di Bari F; Bozzi V; Gresele P; Lethagen S; Fabris F; Dufour C; Granata A; Doubek M; Pecoraro C; Koivisto PA; Heller PG; Iolascon A; Alvisi P; Schwabe D; De Candia E; Rocca B; Russo U; Ramenghi U; Noris P; Seri M; Balduini CL; Savoia A
    Hum Mutat; 2008 Mar; 29(3):409-17. PubMed ID: 18059020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of a novel in-frame deletion mutation of the MYH9 gene with end-stage renal failure: case report and review of the literature.
    Ishida M; Mori Y; Ota N; Inaba T; Kunishima S
    Clin Nephrol; 2013 Sep; 80(3):218-22. PubMed ID: 22541678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of the first large deletion of the MYH9 gene associated with MYH9 disorders.
    Kunishima S; Matsushita T; Hamaguchi M; Saito H
    Eur J Haematol; 2008 Jun; 80(6):540-4. PubMed ID: 18284620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivation.
    Toren A; Rozenfeld-Granot G; Heath KE; Amariglio N; Rocca B; Crosson J; Epstein CJ; Laghi F; Landolfi R; Carlsson LE; Argraves S; Bizzaro N; Moxey-Mims M; Brok-Simoni F; Martignetti JA; Greinacher A; Rechavi G
    Am J Hematol; 2003 Dec; 74(4):254-62. PubMed ID: 14635206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cochlear implants for DFNA17 deafness.
    Hildebrand MS; de Silva MG; Gardner RJ; Rose E; de Graaf CA; Bahlo M; Dahl HH
    Laryngoscope; 2006 Dec; 116(12):2211-5. PubMed ID: 17146397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of unique neutrophil non-muscle myosin heavy chain-A localization by immunofluorescence analysis in MYH9 disorder presented with macrothrombocytopenia without leukocyte inclusions and deafness.
    Kunishima S; Matsushita T; Shiratsuchi M; Ikuta T; Nishimura J; Hamaguchi M; Naoe T; Saito H
    Eur J Haematol; 2005 Jan; 74(1):1-5. PubMed ID: 15613099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrothrombocytopenia and progressive deafness is due to a mutation in MYH9.
    Mhatre AN; Kim Y; Brodie HA; Lalwani AK
    Otol Neurotol; 2003 Mar; 24(2):205-9. PubMed ID: 12621333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of clinical manifestations, mutant gene and encoded protein in two Chinese MYH9-related disease families.
    Yi Y; Sen Zhang G; Xu M; San Ling Z; Ru Shao X; Zeng Li J; Ma J
    Clin Chim Acta; 2006 Nov; 373(1-2):49-54. PubMed ID: 16806139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.